SCHEMBL24569838

SCHEMBL24569838

CC1(C)c2ccccc2N2c3cc(-c4ccccc4)ccc3C3(c4ccccc4C(=O)c4ccccc43)c3cccc1c32

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMS P04818 1/20 0.35
MAPT P10636 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
APAF1 O14727 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
THRB P10828 1/20 0.33
XBP1 P17861 1/20 0.33
PTBP1 P26599 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
GALK1 P51570 1/20 0.33
BLM P54132 1/20 0.33
SMAD3 P84022 1/20 0.33
ATM Q13315 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PDE6D O43924 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24569265 1.00 TYMS (0.35) TYMSMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL24608660 0.92 PGR (0.35) TYMSMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL24569754 0.88 PGR (0.39) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL24608659 0.86 PGR (0.32) TYMSMEN1KMT2AALDH1A1PGR
SCHEMBL24608648 0.86 PGR (0.37) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL24608661 0.86 MEN1 (0.31) MAPTMEN1KMT2AMAPK1
SCHEMBL24608704 0.83 ALDH1A1 (0.40) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL24608646 0.83 ALDH1A1 (0.43) MAPTMEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL24608728 0.83 MEN1 (0.34) TYMSMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL24608664 0.80 KMT2A (0.37) MAPTMEN1KMT2ANPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917912-B2 Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source CANON KABUSHIKI KAISHA (JP) 2024-02-27 US disclosed
US-11917912-B2 Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source CANON KABUSHIKI KAISHA (JP) 2024-02-27 US disclosed
US-20220216423-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC APPARATUS, ILLUMINATION APPARATUS, MOVING OBJECT, AND EXPOSURE LIGHT SOURCE CANON KABUSHIKI KAISHA (JP) 2022-07-07 US disclosed
EP-4019504-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC APPARATUS, ILLUMINATION APPARATUS, MOVING OBJECT, AND EXPOSURE LIGHT SOURCE CANON KABUSHIKI KAISHA (JP) 2022-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917912-B2 Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source AOX1, SOD1, L1CAM TYMS 3702/4885MAPT 2558/4885MEN1 2311/4885
US-20220216423-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC APPARATUS, ILLUMINATION APPARATUS, MOVING OBJECT, AND EXPOSURE LIGHT SOURCE AOX1, SOD1, L1CAM TYMS 3702/4885MAPT 2558/4885MEN1 2311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.